(Q79984770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Y Y Yuan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

P J Kostenuik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M S Ominsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S Morony

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S Adamu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

D T Simionescu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

D M Basalyga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

F J Asuncion

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

T A Bateman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

24 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

625-635

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18038244%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-007-0509-7

27 December 2019

exact match

0 references

cites work

Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis.

1 reference

12 December 2020

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

12 December 2020

Skeletal complications of malignancy

1 reference

12 December 2020

Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins

1 reference

12 December 2020

Bone resorption by osteoclasts

1 reference

12 December 2020

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

12 December 2020

The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction

1 reference

12 December 2020

Osteoclast differentiation and activation

1 reference

12 December 2020

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Osteoprotegerin Levels in Primary Hyperparathyroidism: Effect of Parathyroidectomy and Association with Bone Metabolism

1 reference

12 December 2020

Effects of rehydration state on the flexural properties of whole mouse long bones

1 reference

12 December 2020

Is the paradigm shifting?

1 reference

12 December 2020

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

12 December 2020

Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures.

1 reference

12 December 2020

Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics

1 reference

12 December 2020

RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis

1 reference

12 December 2020

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

12 December 2020

Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?

1 reference

12 December 2020

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

1 reference

12 December 2020

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 December 2020

Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation

1 reference

12 December 2020

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

12 December 2020

Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.

1 reference

12 December 2020

Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism

1 reference

12 December 2020

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

1 reference

12 December 2020

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer

1 reference

12 December 2020

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

12 December 2020

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis

1 reference

12 December 2020

Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle

1 reference

12 December 2020

Biomechanics of bone: determinants of skeletal fragility and bone quality

1 reference

12 December 2020

Regulation of osteoclastogenesis by three human RANKL isoforms expressed in NIH3T3 cells

1 reference

12 December 2020

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

1 reference

12 December 2020

Denosumab in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

1 reference

12 December 2020

The effects of osteoprotegerin on the mechanical properties of rat bone

1 reference

12 December 2020

Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.

1 reference

12 December 2020

The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis

1 reference

12 December 2020

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

12 December 2020

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

1 reference

12 December 2020

Osteoclast resorption-stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix

1 reference

12 December 2020